The nuclear medicine/radiopharmaceuticals market was valued at US$ 6.5 billion in 2019.
The global radiopharmaceuticals market is estimated to exhibit a CAGR of 8.9% in terms of revenue over the forecast period.
Rising occurrences of cardiovascular diseases at a global scale is anticipated to favor the growth of global radiopharmaceuticals market.
Asia Pacific is projected to witness lucrative growth over the forecast period. The growth of the region can be attributed to rising aging population and increasing awareness for molecular imaging and nuclear medicines across the region.
North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved